Marijuana Co of America, Inc. (MCOA) financial statements (2022 and earlier)
Company profile
| Business Address |
633 W. 5TH STREET LOS ANGELES, CA 90071 |
| State of Incorp. | UT |
| Fiscal Year End | December 31 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 314 | 239 | 1,170 | |||
| Cash and cash equivalents | 75 | 212 | 360 | |||
| Short-term investments | 239 | 27 | 810 | |||
| Receivables | 9 | 18 | 46 | |||
| Inventory, net of allowances, customer advances and progress billings | 103 | 149 | 187 | |||
| Inventory | 103 | 149 | 187 | |||
| Prepaid expense | 56 | |||||
| Other current assets | 56 | 11 | 94 | |||
| Total current assets: | 538 | 418 | 1,497 | |||
| Noncurrent Assets | ||||||
| Finance lease, right-of-use asset | 8 | 22 | ✕ | |||
| Property, plant and equipment | 7 | 8 | 12 | |||
| Long-term investments and receivables | 1,552 | 694 | 408 | |||
| Long-term investments | 1,552 | 694 | 408 | |||
| Other undisclosed noncurrent assets | 3 | 3 | 3 | |||
| Total noncurrent assets: | 1,569 | 726 | 423 | |||
| TOTAL ASSETS: | 2,106 | 1,144 | 1,920 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 962 | 1,355 | 1,088 | |||
| Accounts payable | 481 | 798 | 416 | |||
| Accrued liabilities | 401 | 552 | 217 | |||
| Employee-related liabilities | 79 | 5 | 454 | |||
| Debt | 1,462 | 3,194 | 290 | |||
| Derivative instruments and hedges, liabilities | 4,426 | 5,693 | 2,257 | |||
| Due to related parties | 40 | 40 | 287 | |||
| Other undisclosed current liabilities | 678 | 1,464 | 1,133 | |||
| Total current liabilities: | 7,568 | 11,745 | 5,054 | |||
| Noncurrent Liabilities | ||||||
| Total liabilities: | 7,568 | 11,745 | 5,054 | |||
| Stockholders' equity | ||||||
| Stockholders' equity attributable to parent, including: | (5,461) | (10,609) | (3,134) | |||
| Preferred stock | 10 | 10 | ||||
| Common stock | 3,137 | 78 | 2,561 | |||
| Common stock, value, subscriptions | 90 | |||||
| Additional paid in capital | 77,688 | 63,467 | 48,189 | |||
| Accumulated deficit | (86,310) | (74,164) | (53,984) | |||
| Other undisclosed stockholders' equity attributable to parent | 24 | |||||
| Other undisclosed stockholders' equity | 8 | |||||
| Total stockholders' equity: | (5,461) | (10,601) | (3,134) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,106 | 1,144 | 1,920 | |||
Income statement (P&L) ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|
| Revenues | 281 | 695 | 252 | ||
| Cost of revenue | (159) | (249) | (81) | ||
| Gross profit: | 121 | 447 | 171 | ||
| Operating expenses | (4,976) | (6,917) | (3,986) | ||
| Operating loss: | (4,855) | (6,471) | (3,815) | ||
| Nonoperating expense | (7,290) | (13,710) | (7,281) | ||
| Interest and debt expense | 78 | (3,771) | (1,343) | ||
| Net loss: | (12,068) | (23,951) | (12,439) | ||
| Other undisclosed net income (loss) attributable to parent | (78) | 3,771 | 1,343 | ||
| Net loss available to common stockholders, diluted: | (12,145) | (20,180) | (11,096) | ||
Comprehensive Income ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|
| Net loss: | (12,068) | (23,951) | (12,439) | ||
| Comprehensive loss, net of tax, attributable to parent: | (12,068) | (23,951) | (12,439) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.